HANNAH PIERCE: Open Payments
NPI 1053024570 · LONGMONT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $130 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $74 |
| ABBVIE INC. | 3 | $57 |
| UCB, Inc. | 2 | $40 |
| Lilly USA, LLC | 1 | $29 |
| Integra LifeSciences Corporation | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: NEMLUVIO, RINVOQ, Bimzelx, TALTZ, Integra, DUPIXENT, TREMFYA, SKYRIZI.
Industry payments across CO — which companies pay providers there.
